Orolingual angioedema associated with olmesartan use after recombinant tissue plasminogen activator treatment of acute stroke.
Department of Neurology, Navy 411 Hospital, Shanghai, People's Republic of China.
Shi
S
Wang
Department of Neurology, Changhai Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Xiaoying
X
Bi
Department of Neurology, Navy 411 Hospital, Shanghai, People's Republic of China.
Lianbiao
L
Shan
Department of Neurology, Navy 411 Hospital, Shanghai, People's Republic of China. Electronic address: zhouyingqi81@163.com.
Yingqi
Y
Zhou
D000208:Acute Disease; D000369:Aged, 80 and over; D000799:Angioedema / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008046:Lip / Q000187:drug effects / Q000473:pathology; D008775:Methylprednisolone / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D020521:Stroke / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D013777:Tetrazoles / Q000008:administration & dosage*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014059:Tongue / Q000187:drug effects / Q000473:pathology; D014609:Uvula / Q000187:drug effects / Q000473:pathology
D000959:Antihypertensive Agents; D007093:Imidazoles; D011994:Recombinant Proteins; D013777:Tetrazoles; C437965:olmesartan; D010959:Tissue Plasminogen Activator; D008775:Methylprednisolone